3.4600
+0.0600
+(1.76%)
At close: January 31 at 5:05:05 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
6,908.5340
3,063.4610
2,355.3150
Investing Cash Flow
-2,931.1870
-1,998.5380
-1,941.3780
Financing Cash Flow
-1,930.9550
-1,686.7080
-1,141.2860
End Cash Position
4,854.4610
4,250.6280
4,872.4130
Capital Expenditure
-2,377.4690
-1,783.2120
-1,916.7110
Issuance of Capital Stock
73.0500
112.4100
--
Issuance of Debt
-50.0000
79.2390
650.0000
Repayment of Debt
-1,880.9550
-1,805.3070
-1,791.2860
Repurchase of Capital Stock
--
-73.0500
--
Free Cash Flow
4,531.0650
1,280.2490
438.6040
12/31/2022 - 5/7/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1GDA.F Zevra Therapeutics, Inc.
7.65
+2.68%
GYX.F Futura Medical plc
0.1750
-50.00%
1BT.F Enlivex Therapeutics Ltd.
1.0500
0.00%
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
HQ1.MU Oruka Therapeutics Inc. R
12.00
+5.26%
CVAC.VI CureVac N.V.
3.6780
-2.13%
ZSB.F Sirona Biochem Corp.
0.0335
-2.90%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4690
+1.52%
471A.F aTyr Pharma, Inc.
3.5800
+3.47%